Mereo BioPharma Group plc (MREO)
NASDAQ: MREO · Real-Time Price · USD
4.010
-0.270 (-6.31%)
At close: Nov 4, 2024, 4:00 PM
4.100
+0.090 (2.24%)
Pre-market: Nov 5, 2024, 8:10 AM EST
Mereo BioPharma Group Employees
Mereo BioPharma Group had 33 employees as of December 31, 2023. The number of employees decreased by 3 or -8.33% compared to the previous year.
Employees
33
Change (1Y)
-3
Growth (1Y)
-8.33%
Revenue / Employee
$30,303
Profits / Employee
-$1,116,576
Market Cap
615.96M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Fulgent Genetics | 1,184 |
Pacific Biosciences of California | 796 |
OrthoPediatrics | 247 |
AnaptysBio | 117 |
ORIC Pharmaceuticals | 100 |
Y-mAbs Therapeutics | 100 |
Olema Pharmaceuticals | 74 |
ABIVAX Société Anonyme | 61 |
MREO News
- 7 weeks ago - Mereo BioPharma to Participate in Fireside Chat at the 2024 Cantor Global Healthcare Conference - GlobeNewsWire
- 3 months ago - Mereo BioPharma Reports Second Quarter 2024 Financial Results and Provides Corporate Update - GlobeNewsWire
- 5 months ago - Mereo BioPharma Announces Pricing of $50 Million Underwritten Registered Direct Offering of American Depository Shares, Priced At-the-Market - GlobeNewsWire
- 5 months ago - Mereo BioPharma to Participate in Fireside Chat at the Jefferies Global Healthcare Conference - GlobeNewsWire
- 6 months ago - Mereo BioPharma Reports First Quarter 2024 Financial Results and Provides Corporate Update - GlobeNewsWire
- 7 months ago - Mereo BioPharma to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference - GlobeNewsWire
- 7 months ago - Mereo BioPharma Reports Full Year 2023 Financial Results and Provides Corporate Update - GlobeNewsWire
- 8 months ago - Newer Treatments In Alpha-1 Antitrypsin Deficiency: $2.5 Billion/Year Market Size By 2032 - Seeking Alpha